Because the underlying molecular mechanisms of the pathophysiological interaction between Aβ and tau are unclear, ADLPAPT mice may enable further exploration of the Aβ-tau axis hypothesis on the progression of AD pathogenesis. This evidence concerns the gene MAPT and Alzheimer disease.